Capacity Expansions

Demand for Sartorius Products is Growing Rapidly

Sartorius expects continuous strong growth for the current fiscal year and beyond.  To support this growth, and to ensure delivery reliability going forward, we have started to accelerate and extend the expansion of our production capacities very significantly in all geographies, the Americas, Europe, and Asia. By 2025, Sartorius will more than double capacities for key product groups. We will also expand our presence with customers, particularly in China and the United States, by setting up Customer Interaction Centers and investing in a very significant expansion of our activities in South Korea.

In 2021 alone, Sartorius invested around €400 million worldwide. Investments will further increase in 2022 and are expected to reach a CAPEX ratio of about 14 percent. They will continue to be focused on the expansion of production capacities in all regions.

€400 million worldwide investment in 2021

Interactive Map: Global Expansion of Production Capacities

New Customer Interaction Centers in all Regions

Sartorius has opened new Customer Interaction Centers (CIC) in Germany, China, and the United States. The CICs provide a space for demonstrations and factory acceptance testing of instruments and systems. This will enable customers to test, validate, and adjust the functionalities of their equipment prior to installation at their sites.

Marlborough, USA

Customer Interaction Center operational since 2021

Learn More

Guxhagen, Germany

Customer Interaction Center opening late 2022

Learn More

Beijing, China

Customer Interaction Center operational since 2021

Learn More

Significant Increase of Capacities for Key Products by 2025


Sartorius' extensive filtration and purification portfolio helps you overcome your major challenges.

Explore More

Fluid Management

With over 20 years of experience in manufacturing reliable, economical and safe solutions, we are your best partner for manufacturing facilities.

Explore More

Instruments & Systems

Sartorius offers complete scalable bioreactor platforms from cell and strain line development to commercial manufacturing.

Explore More



Local Contact

Learn More

Investor Relations

Learn More


Learn More